Certified by Founder Lodge
Callio Therapeutics
-
START UP
1 Disclosed Funding Rounds $187,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Realizing the promise of multi-payload antibody-drug conjugates to improve cancer therapy
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 06 ,2025 | Series A | $187,000,000 |
SEEDS Capital
EDBI Pte Ltd
Omega Funds
Pureos Bioventures
ClavystBio
Frazier Life Sciences
Platanus
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
